John Frederick Ek - Mar 20, 2023 Form 3 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Chief Financial Officer
Signature
/s/John Frederick Ek, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Mar 20, 2023
Transactions value $
$0
Form type
3
Date filed
3/21/2023, 05:50 PM
Next filing
Jun 12, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24.1 Power of Attorney